Literature DB >> 30127911

MicroRNA-376a regulates cell proliferation and apoptosis by targeting forkhead box protein P2 in lymphoma.

Shuna Yao1, Yanyan Liu1, Zhihua Yao1, Yan Zhao1, Haiying Wang1, Yuanlin Xu1, Jiuyang Zhang1, Jing Li1, Shujun Yang1.   

Abstract

The present study aimed to investigate microRNA-376a (miR-376a) expression in lymphoma, and to investigate the effect of miR-376a on cell proliferation and apoptosis at cytological and molecular levels. The expression of miR-376a in lymphoma issue and cells was detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR), the expression of forkhead box protein P2 (FOXP2) was detected by RT-qPCR and western blot analysis, and the effect of miR-376a on cell proliferation and apoptosis were studied by an MTT assay and flow cytometry, respectively. Additionally, the expression levels of cyclin D2, cyclin A, cyclin B, apoptosis-associated proteins B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax) were detected by western blot analysis. Furthermore, the target of miR-376a was predicted and clarified using a dual-luciferase reporter assay. The expression of miR-376a was downregulated and FOXP2 was upregulated in lymphoma tissues and cells. miR-376a overexpression inhibited lymphoma cell proliferation and induced apoptosis by regulating the expression levels of cyclin D2, cyclin A, Bax and Bcl-2. The dual-luciferase reporter assay demonstrated that FOXP2 was a target of miR-376a. miR-376a overexpression induced apoptosis by targeting FOXP2. Overexpression of miR-376a inhibited cell proliferation and induced apoptosis by targeting FOXP2 in lymphoma. Therefore, miR-376a and FOXP2 have the potential for use as biomarkers of lymphoma.

Entities:  

Keywords:  cell apoptosis; cell proliferation; forkhead box protein P2; lymphoma; microRNA-376a

Year:  2018        PMID: 30127911      PMCID: PMC6096197          DOI: 10.3892/ol.2018.9012

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.

Authors:  K Musilova; M Mraz
Journal:  Leukemia       Date:  2014-12-26       Impact factor: 11.528

Review 3.  Cyclins and oncogenesis.

Authors:  T Motokura; A Arnold
Journal:  Biochim Biophys Acta       Date:  1993-05-25

Review 4.  Systemic mirnas as potential biomarkers for malignancy.

Authors:  N A Healy; H M Heneghan; N Miller; C K Osborne; R Schiff; M J Kerin
Journal:  Int J Cancer       Date:  2012-07-30       Impact factor: 7.396

Review 5.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

6.  Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.

Authors:  Alberto J Arribas; Cristina Gómez-Abad; Margarita Sánchez-Beato; Nerea Martinez; Lorena Dilisio; Felipe Casado; Miguel A Cruz; Patrocinio Algara; Miguel A Piris; Manuela Mollejo
Journal:  Mod Pathol       Date:  2013-02-22       Impact factor: 7.842

7.  FoxP2 regulates neurogenesis during embryonic cortical development.

Authors:  David Tsui; John P Vessey; Hideaki Tomita; David R Kaplan; Freda D Miller
Journal:  J Neurosci       Date:  2013-01-02       Impact factor: 6.167

8.  The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas.

Authors:  J Bartkova; J Lukas; M Strauss; J Bartek
Journal:  Int J Cancer       Date:  1994-08-15       Impact factor: 7.396

9.  FoxP4, a novel forkhead transcription factor.

Authors:  Andreas Teufel; Eric A Wong; Mahua Mukhopadhyay; Nasir Malik; Heiner Westphal
Journal:  Biochim Biophys Acta       Date:  2003-06-19

10.  Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.

Authors:  Liron Zehavi; Roi Avraham; Aviv Barzilai; Dalia Bar-Ilan; Roy Navon; Yechezkel Sidi; Dror Avni; Raya Leibowitz-Amit
Journal:  Mol Cancer       Date:  2012-07-02       Impact factor: 27.401

View more
  7 in total

1.  Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension.

Authors:  Grayson L Baird; Thomas Walsh; Jason Aliotta; Melissa Allahua; Ruth Andrew; Ghada Bourjeily; Alexander S Brodsky; Nina Denver; Mark Dooner; Elizabeth O Harrington; James R Klinger; Margaret R MacLean; Christopher J Mullin; Mandy Pereira; Athena Poppas; Mary Whittenhall; Corey E Ventetuolo
Journal:  Ann Am Thorac Soc       Date:  2021-02

Review 2.  Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression.

Authors:  Ju-Ha Kim; Jisung Hwang; Ji Hoon Jung; Hyo-Jung Lee; Dae Young Lee; Sung-Hoon Kim
Journal:  Mol Cancer       Date:  2019-12-09       Impact factor: 27.401

3.  Tumor Suppressor Function of miR-127-3p and miR-376a-3p in Osteosarcoma Cells.

Authors:  Joerg Fellenberg; Burkhard Lehner; Heiner Saehr; Astrid Schenker; Pierre Kunz
Journal:  Cancers (Basel)       Date:  2019-12-14       Impact factor: 6.639

4.  Silencing long intergenic non-protein coding RNA 00987 inhibits proliferation, migration, and invasion of osteosarcoma cells by sponging miR-376a-5p to regulate FNBP1 expression.

Authors:  Riliang Cao; Jianli Shao; Wencai Zhang; Yongxin Lin; Zerong Huang; Zhizhong Li
Journal:  Discov Oncol       Date:  2021-06-01

5.  miR-134-5p promotes inflammation and apoptosis of trophoblast cells via regulating FOXP2 transcription in gestational diabetes mellitus.

Authors:  Weiqi Ke; Yixiang Chen; Lijing Zheng; Yuting Zhang; Yudan Wu; Li Li
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

6.  The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients.

Authors:  Paweł Robak; Izabela Dróżdż; Dariusz Jarych; Damian Mikulski; Edyta Węgłowska; Monika Siemieniuk-Ryś; Małgorzata Misiewicz; Konrad Stawiski; Wojciech Fendler; Janusz Szemraj; Piotr Smolewski; Tadeusz Robak
Journal:  Cancers (Basel)       Date:  2020-09-09       Impact factor: 6.639

7.  miR-376a-3p and miR-376b-3p overexpression in Hutchinson-Gilford progeria fibroblasts inhibits cell proliferation and induces premature senescence.

Authors:  Diane Frankel; Valérie Delecourt; Elva-María Novoa-Del-Toro; Jérôme D Robin; Coraline Airault; Catherine Bartoli; Aurélie Carabalona; Sophie Perrin; Kilian Mazaleyrat; Annachiara De Sandre-Giovannoli; Frederique Magdinier; Anaïs Baudot; Nicolas Lévy; Elise Kaspi; Patrice Roll
Journal:  iScience       Date:  2022-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.